Search

everythinglearnresearchcommunity

for

Search:↓

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Chemotherapy and radiotherapy do not significantly affect obstructive sleep apnea development.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

Early detection of chemotherapy side effects allows treatment adjustments, improving patient outcomes.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Chemotherapy improved a girl's painful foot condition linked to pachyonychia congenita.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

CHOP chemotherapy causes many side effects but is generally well tolerated.